This revolutionary approach has given hope to patients who previously had limited or no options, particularly those battling ...

This turns them into CAR T cells. Before you get your CAR T cells back, you will get chemotherapy to prepare your body for treatment. When your CAR T cells come from the lab, we put them back in your ...

A clinical team has spearheaded the use of CAR-T cell therapy for blood cancers. The researchers recently treated the first myeloma patient with this therapy, resulting in a very good response without ...

Discover the long-term results of CAR T-cell therapy, with and without stem cell transplantation, for relapsed lymphoma ...

CAR-T therapy for myeloma faces challenges in early-line use due to accessibility, eligibility criteria and long wait times, ...

Researchers in South Korea have proposed a novel cancer immunotherapy approach that could complement existing CAR-T (Chimeric ...

Chimeric antigen receptor t-cell, or CAR-T therapy, uses a person’s own immune cells to attack cancer. Dean Berhaupt is the ...

CAR-T cell therapy is an individualised treatment ... intravenous infusion following the administration of a round of chemotherapy designed to accommodate the new cells and minimise the patient ...

SANTA MONICA, Calif.–(BUSINESS WIRE)–Jun 28, 2021– Kite, a Gilead Company (Nasdaq: GILD), today announced top-line results from the primary analysis of ZUMA-7, a randomized Phase … ...

Emerging data suggests that coupling immunogenic chemotherapy with anti–PD-L1 ... as an option for patients who relapse after CAR T-cell and bispecific antibody therapy,” the authors concluded ...